IMVT · Immunovant, Inc. · Share Buybacks
$28.88
+0.71 (+2.52%)
At close · Oct 27
Return incl. dividend (before tax)
Q3 2026 earnings call transcript
Market Cap
$5.82B
Shares
206.55M
Volume · Oct 27
1.06M
Avg daily vol (3M)
1.34M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Equity Offering (ATM) Programs
| Program Established | Last Amended | Capacity | Remaining | Runs Through | Source |
|---|---|---|---|---|---|
| 2023-11-09 | — | $150,000,000 | — | — | 10-Q , filed 2026-08-06 |
Key facts
CIK
1764013
CUSIP
45258J102
13F (30d)
24 filings
24 filers
Visit website
Investor relations